Skip to search boxSkip to navigationSkip to main content

Mixed pH-sensitive polymeric micelles for combination drug delivery

  • Younsoo Bae(corresponding author)
    ,
  • Adam W.G. Alani
    ,
  • ,
  • T. S.Z.Chung Lai
    ,
  • Glen S. Kwon
*Corresponding author for this work
  • University of Kentucky
    ,
  • University of Wisconsin-Madison
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Purpose: To prepare mixed polymeric micelles that can carry two different drugs, doxorubicin (DOX) and 17-hydroxyethylamino-17-demethoxygeldanamycin (GDM-OH), for combination cancer chemotherapy. Methods: The pH-sensitive micelles were prepared from poly(ethylene glycol)-poly(aspartate hydrazide) block copolymers to which either DOX or GDM-OH is conjugated through acid-labile hydrazone bond (individual micelles). Mixed micelles were formed not only by simply mixing two different individual micelles in aqueous solutions (aqueous mixed micelles) but also by evaporating organic solvents from the organic/aqueous mixed solvents in which two block copolymers possessing different drugs were dissolved homogeneously (organic mixed micelles). Particle size measurements, pH-dependent drug release tests, cytotoxicity assays and western blot analysis were subsequently conducted. Results: Individual and aqueous/organic mixed micelles showed clinically relevant particle size (<100 nm) and pH-dependent drug release patterns. Mixed polymer micelles suppress cancer cell growth effectively in a drug concentration, mixing method and schedule-dependent way. Conclusion: Combination chemotherapy using polymeric micelles seems to minimize a schedule-dependent change in combination drug efficacy in comparison to drug combination using DMSO formulations.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 2421-2432 (12 pages)

Journal (Volume, Issue Number)

Pharmaceutical Research (Volume 27, Issue 11)

Publication milestones

  • Published - 11/2010

Publication status

Published - 11/2010

ISSN

0724-8741

Publication IDs

  • Scopus: 78549293222
  • PubMed: 20700632
  • ORCID: /0000-0002-2898-4393/work/192618479

Publication metrics

Metrics

Fractional count
1
Fractional count
0.20
Fractional count
4
Fractional count
0.80
Fractional count
1
Fractional count
1
SciVal
FWCI
2.22
SciVal
Author count
5
SciVal
citations
47
SciVal
Paper percentile
89
Scopus
citations

PlumX, opens in new tab

Captures
44
Citation count
50

Funding Details

This work was partially supported by National Institutes of Health grant R01 AI-43346-08. Y.B. acknowledges research support provided by the Kentucky Lung Cancer Research Program.
FundersFunding numbers
Kentucky Lung Cancer Research Program
-
NIH
R01 AI-43346-08
NIAID
R01AI043346